Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07170566 · ClinicalTrials.gov registry record
A Retrospective, Observational Study of the Real-world Safety and Performance of InnovaMatrix® AC at a Single Centre
A clinical trial, sponsored by ConvaTec.
- Completed
- Registry status
- 67
- Enrollment target
NCT07170566 is a clinical trial that has completed, run by ConvaTec. The registered enrollment target is 67 participants.
The verdict
NCT07170566 has completed, sponsored by ConvaTec.
- COMPLETED
- Registry status
- 67 participants
- Enrollment target
Study Summary
The use of a decellularised porcine placental extracellular matrix in hard-to-heal wounds: A retrospective study of the real-world performance of InnovaMatrix® AC at a single centre.
Interventions
- DEVICE innovaMatrix AC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2024-05-01 |
| Est. Completion | 2025-08-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07170566
The ClinicalTrials.gov registry entry for NCT07170566 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ConvaTec, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which innovaMatrix AC is the first listed.
NCT07170566 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07170566 about?
NCT07170566 is a clinical study titled "A Retrospective, Observational Study of the Real-world Safety and Performance of InnovaMatrix® AC at a Single Centre". The use of a decellularised porcine placental extracellular matrix in hard-to-heal wounds: A retrospective study of the real-world performance of InnovaMatrix® AC at a single centre.
What is the current status of trial NCT07170566?
This trial is currently completed. The enrollment target is 67 participants. The study started on 2024-05-01. Estimated completion is 2025-08-05.
What interventions are being tested in trial NCT07170566?
The interventions under investigation include: innovaMatrix AC (DEVICE).
Who is sponsoring clinical trial NCT07170566?
This trial is sponsored by ConvaTec, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.